Patient Site Healthcare Professional Site

USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that act
directly on the renin-angiotensin system can cause injury and even death to the
developing fetus. 
When pregnancy is detected, BENICAR or BENICAR HCT should be
discontinued as soon as possible. See WARNINGS, Fetal/Neonatal Morbidity and
Mortality
in the prescribing information.

BENICAR/BENICAR HCT has not been shown to have any correlation to athletic performance.

Click here for full prescribing information for Benicar and Benicar HCT,
including boxed WARNING regarding use in pregnancy.
This information is intended for U.S. residents only.


© 2008 Daiichi Sankyo, Inc.
Terms of Use and Privacy Policy